There was high risk of bias in two studies because of low methodological quality. One study comparing acupuncture with medication concluded that both methods were effective in controlling pain, although acupuncture was the most effective. The second study compared acupuncture, point-injection and medication in participants with stomach cancer. Long-term pain relief was reported for both acupuncture and point-injection compared with medication during the last 10 days of treatment. Although both studies have positive results in favour of acupuncture they should be viewed with caution due to methodological limitations, small sample sizes, poor reporting and inadequate analysis.
Authors' conclusions
There is insufficient evidence to judge whether acupuncture is effective in treating cancer pain in adults.
P L A I N L A N G U A G E S U M M A R Y

Acupuncture for cancer-related pain in adults
Up to 70% of patients with cancer-related pain do not receive adequate pain relief and this reduces their quality of life. Acupuncture may have a role to play in relieving cancer-related pain. This review evaluated evidence for the effectiveness of acupuncture in reducing pain associated with cancer or its treatment, or both. We found three studies (looking at a total of 204 participants) which met our inclusion criteria, but all had small sample sizes, leaving them prone to bias, and only one study was judged to be of high methodological quality. The high quality study found that auricular (ear) acupuncture reduced cancer-related pain when compared with auricular acupuncture at non acupuncture points, but the control group was not adequately blinded and this was likely to affect the outcomes. Of the low quality studies, one found that acupuncture was as effective as medication, and one study found that acupuncture was more effective than medication, but both studies were poorly designed and the study reports lacked detail. We concluded that there was insufficient evidence to judge whether acupuncture is effective in relieving cancer-related pain in adults.
B A C K G R O U N D Description of the condition
Cancer-related pain represents a major challenge in healthcare. 
Description of the intervention
Acupuncture is a treatment intervention delivered by practitioners aligned to different philosophical paradigms (MacPherson 2007) . Acupuncture is used throughout the world to manage non-malignant acute and chronic pain. It is claimed that acupuncture has a role in the management of cancer pain (Alimi 2003; Dillon 1999; Filshie 2004 ) and guidelines exist for the acupuncture treatment of cancer pain (Filshie 2006) . Anecdotal evidence suggests that it is routinely used in clinical practice by physiotherapists for a variety of pain states (Hopwood 2004 ) and increasingly by the medical profession for pain relief in general (MacPherson 2007). Filshie 1990 described the use of acupuncture for malignant pain on 193 cancer patients over a five year period and reported that 56% of patients had a 'worthwhile' improvement for seven days or more and 22% had an improvement for a 'limited duration'. A further 22% obtained no benefit at all. There continues to be a debate about the efficacy of acupuncture (Ernst 2006). Some systematic reviews and meta-analyses report that acupuncture is superior to placebo or sham acupuncture for . A systematic review of systematic reviews of acupuncture published between 1996 to 2005, claimed to apply more rigorous inclusion criteria than previous reviews and concluded that there was no robust evidence that acupuncture is superior to a sham acupuncture control (Derry 2006). Trials comparing both acupuncture and sham acupuncture with patients on a waiting list tended to show benefits of both acupuncture and sham over the waiting list group. Sham acupuncture can either be a nonpenetrative sham (i.e. it has the appearance of real acupuncture but the needle is blunt and does not penetrate the skin) or penetrative sham (i.e. where the needle penetrates the skin but is used on non-acupuncture points). It has been suggested that the dosage of acupuncture required for a beneficial effect is a minimum of six treatments using at least four points at a frequency of at least once a week, although the evidence supporting these recommendations has not been widely researched (Ezzo 2000; White 2007). White 2007 also suggests that the needle sensation, 'de qi', or in electroacupuncture a strong sensation of paraesthesiae must be achieved for optimum benefit. To date, there has only been one systematic review of acupuncture for cancer pain (Lee 2005). This was not conducted using a Cochrane protocol. Seven studies met the eligibility criteria: three were RCTs and four were uncontrolled studies. Only one small RCT was identified (Alimi 2003), and the investigators concluded that auricular (ear) acupuncture provided statistically significant pain relief when compared with placebo acupuncture. It was not possible to meta-analyse the results of the review due to heterogeneity in pain states, patient populations and acupuncture protocols in the identified studies. Four studies used body acupuncture, two used auricular acupuncture and one used electro-acupuncture (where an electric current is transmitted via the needles). Control groups used were either patients receiving conventional therapies or placebo/sham acupuncture. The review authors concluded that there was insufficient good quality evidence to determine the effectiveness of acupuncture in relieving cancer pain. More recently, Bardia et al (Bardia 2006) conducted a systematic review of the effectiveness of complementary and alternative medicine therapies for cancer related pain but was unable to evaluate the efficacy of acupuncture because of insufficient good quality evidence. Bone metastases are common in advanced cancers, particularly in patients with multiple myeloma, breast, prostate or lung cancer (Brainin-Mattos 2006; Lipton 2004). The incidence of bone involvement has been said to exceed 90% in metastatic prostate and breast cancers (Rosier 1998). Bone pain due to metastatic cancer is severe, unremitting and poorly controlled (Gralow 2007; Ripamonti 2000). Mainstay treatments are opiates and bisphosphonates, although they can have severe adverse effects (Petrut 2008). Nowadays, the survival rate of many patients after diagnosis of bone metastases is relatively long; five year survival rates have been quoted at 64% for metastatic breast disease and 46% for metastatic prostate cancers (Coleman 2001). In view of this it is important to control pain and preserve function to enable these patients to enjoy as high a quality of life as possible (Qaseem 2008) . Filshie 1990 claims that acupuncture is useful in 'selected' patients with CIBP, where pain is difficult to control adequately and pharmacological input is very high, resulting in unpleasant side-effects. To date, no systematic reviews on acupuncture for CIBP have been conducted and therefore the efficacy of acupuncture as a treatment for CIBP is unknown. The high incidence of CIBP merits a subgroup analysis, although preliminary searches have not revealed any controlled trials. It is necessary to establish whether any studies exist, the quality of the research and any important findings. Within the review as a whole and in the subgroup analysis on CIBP, studies with heterogeneous cancer populations will not be excluded. However, heterogeneous studies will be identified and discussed as part of the review.
Why it is important to do this review
O B J E C T I V E S
To evaluate the efficacy of acupuncture for the relief of cancerrelated pain in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) (crossover or parallel group design) which evaluated any type of invasive acupuncture for cancer-related pain in adults were included, from inception of each database onwards. These included studies which did not blind the therapist because blinding an acupuncturist to the treatment is problematical.
Studies were excluded if they were non-randomised trials, case reports, abstracts and letters (unless additional information from published RCTs was included).
Types of participants
Male and/or female adult participants of 18 years or older were included. They had cancer-related pain (as defined by commonly used verbal rating scales or questionnaires), which was thought to be directly linked to the development of their cancer and not due to pre-existing pathologies or related to treatments; for example, chemotherapy-induced neuropathic pain (Cata 2006); or procedures such as surgery. We intended to review CIBP as our subgroup analysis if the data allowed.
Types of interventions
Studies which evaluated any type of invasive acupuncture were included. This included studies using manual acupuncture, electroacupuncture and auricular (ear) acupuncture. Both Western style and traditional Chinese acupuncture were included. Western-style acupuncture is characterised by its scientific approach, using a physiologically-based rationale for the treatment and explanation of its effects, whereas traditional Chinese acupuncture is based on the ancient principles of Chinese medicine. Studies using different forms of needle stimulation (such as electroacupuncture) and different needling techniques were also included, but studies using comparisons of non-invasive techniques such as laser acupuncture or acupressure were excluded. Pain outcomes may be compromised in studies which allow free access to analgesic medication. It was planned to include such studies in the review and analyse them as a sub-group for differences in analgesic consumption between groups. It was also intended that a subgroup analysis would be carried out on adequacy of acupuncture based on the following criteria (White 2007):
• number of needles: ≥ 4 acupuncture points;
• needling technique: ≥ 20 minutes per session;
• needle sensation: reported as 'de qi' or needle sensation for manual acupuncture or a 'strong sensation' for electroacupuncture;
• number of treatments: six treatments at least one per week.
The intervention to be compared with acupuncture would include any of the following:
• no treatment;
• treatment as usual;
• non-penetrative sham (i.e. non-invasive treatment);
• penetrative sham (i.e. invasive treatment at nonacupuncture points);
• other active interventions.
Types of outcome measures Primary outcomes
The primary outcome measure was patient reported pain intensity using validated scales (e.g. visual analogue scales (VAS), numerical rating scales) or verbal reporting.
Secondary outcomes
Secondary outcome measures included any of the following:
• pain relief as measured by validated pain scales (e.g. VAS);
• patient satisfaction;
• quality of life;
• analgesic consumption and changes in concurrent treatments;
• hospital attendance/admission (including Hospice admission);
• adverse events (major or minor).
Search methods for identification of studies Electronic searches
The following data sources were searched from the inception of each database until October 2010: 1. the Cochrane Central Register of Controlled Trials (CENTRAL); 2. MEDLINE; 3. EMBASE; 4. PsycINFO; 5. AMED; 6. SPORTDiscus. Detailed search strategies were developed for each electronic database searched in order to identify studies suitable for inclusion in the review. These were based on the search strategy developed for MEDLINE, but were revised according to the database being used (see 
Searching other resources
Reference lists of eligible studies and previous systematic reviews were also reviewed to identify further eligible studies.
Data collection and analysis
The study selection process is shown in Figure 1 .
Selection of studies
Two review authors (CP and OT) with a third review author (MJ) acting as arbiter independently selected the studies to be considered in the review following the literature searches described in the previous section.
Data extraction and management
Data extraction was conducted up to and including October 2010. A search log was completed, showing databases searched and the dates of searches. A data extraction sheet was completed for every study included in the review. Information recorded included details of authors, participants, study design, characteristics of intervention (acupuncture style, type of needle, number of needles, needling technique, needle sensation and number of treatments) and comparator, any adverse effects and baseline/end of study outcomes.
Assessment of risk of bias in included studies
A modified version of the validated Oxford five-point Quality Scale (Jadad 1996; White 1999) was used to assess quality because the original Jadad scale incorporates blinding of the acupuncturist, which is virtually impossible. Two review authors completed the data extraction and scored each study (CP and OT) with a third review author (MJ) acting as arbiter where differences occurred between the two review authors. The scores were used to assess overall quality. The maximum score was five. Studies scoring three or more points were considered as high quality. The points achieved for each of the studies were listed in a table and were used in the assessment of risk of bias Table 1 . Methodological quality was independently assessed using the Cochrane Collaboration's tool for assessing risk of bias in RCTs (Higgins 2008). Risk of bias was summarised and differences in author interpretation of data was settled through discussion.
Measures of treatment effect
It was planned that data from the outcomes of each study would be pooled to provide an overall measure of the effect of acupuncture on cancer-related pain, except where different cut-off points were used (see below). For continuous data, it was intended that results would be presented as weighted mean differences (WMD). However, if different pain scales were used in the acupuncture studies it was planned that this data would be presented using standardised mean differences (SMD) where appropriate. Where dichotomous data existed, relative risk (RR) would be used.
Unit of analysis issues
The problem of dividing categorical data into dichotomous outcomes provides a potential source of bias as study authors might use different cut-off points for the data in each group. It was planned that outcomes from data with different cut-off points or data from clinically heterogeneous studies would not be pooled as described above. Data would be combined for all treatment periods.
Dealing with missing data
It was planned that studies with missing data would be described in the text and illustrated using tables as appropriate. To avoid bias arising from missing data, an intention-to-treat analysis (ITT) would be performed where data was continuous, using the last observation on each participant carried forward until the study endpoint. Where missing dichotomous data was identified it was planned that these would be assigned positive and negative outcomes in equal proportions. If the number of missing values was significant it was decided that it might be necessary to perform a sensitivity analysis to estimate the effect of the ITT analysis on the overall outcome. It was planned that this would be carried out by assuming a positive outcome for all missing data, followed by a negative outcome for the missing data and then assuming that the outcome would lie near the midpoint between the two values. It was decided that studies with a high attrition rate (50% or more) would not be excluded from the review because it was expected that there would be very few studies meeting the inclusion criteria.
Assessment of heterogeneity
It was planned that a Chi squared test would be used to estimate heterogeneity of both the SMD and relative risk (RR). Further analysis could be performed using the I 2 test. If possible, a forest plot would also be constructed for analysis. Where heterogeneity was statistically significant, it was planned that a random-effects model would be used to interpret the results. If heterogeneity was not statistically significant, a fixed-effect model would be used. Potential sources of heterogeneity exist in the outcomes used (e.g. differences in methods of reporting pain), population (differences in cancer site and nature, or cause of pain, age, gender, etc.), comparators used (e.g. sham/placebo, waiting list) and study design. It was planned that all studies identified for the review would be analysed to identify possible sources of heterogeneity and discussed in the text of the review.
Assessment of reporting biases
If the review authors did not find a large number of studies it was decided that publication or inclusion bias would not be assessed. However, if enough studies were available and a meaningful assessment of publication bias could be carried out, it was planned that a funnel plot would be constructed.
Data synthesis
If the data could be combined into a meta-analysis, categorical data would only be included where it could be divided into dichotomous outcomes. If the data could not be combined in a meta-analysis it was decided that this would be summarised in the text and grouped by outcome as appropriate. All data would be entered using RevMan 5 analysis software.
Subgroup analysis and investigation of heterogeneity
Where the data allowed, we planned to separate the outcome analyses and perform a subgroup analysis on outcomes of studies using acupuncture specifically for CIBP.
Sensitivity analysis
It was planned that other sources of heterogeneity would be explored using sensitivity analysis to determine the effects of the method of acupuncture treatment, overall methodological quality and use of ITT analysis. If there were any studies with high attrition rates (over 50%) they were to be removed from the metaanalysis to determine whether the results would be significantly different without them.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies. See the 'Characteristics of included studies' and 'Characteristics of excluded studies' tables.
Results of the search
For inclusion in the review, studies had to meet all of the three main eligibility criteria which were:
• Investigations of acupuncture for cancer pain;
• Studies containing clinical data;
• Randomised controlled trials (RCTs).
Case reports, abstracts and letters were excluded. Where abstracts for RCTs were identified the full reports were sought and included if available. A flowchart showing the selection process is shown in Figure 1 . In total, 253 references were identified from the literature search of which it was possible to exclude 226 from the title alone as not meeting our eligibility criteria. Abstracts were obtained for the remaining 27 studies and a further 10 were excluded because they were not acupuncture studies, were not studies on cancer pain or they were either systematic reviews or not RCTs. Three studies could not be excluded at this stage because they 
Included studies
Three studies (looking at a total of 204 participants) met our criteria for inclusion, please see the 'Characteristics of included studies' table. An additional study was identified (Dang 1997) but because it contained data duplicated in a later report it was included as a secondary reference for an included study (Dang 1998). Alimi 2003 randomly assigned 90 participants with chronic peripheral or central neuropathic pain related to cancer to to one of the three groups:
• Auricular acupuncture using semi-permanent needles;
• Auricular acupuncture using semi-permanent needles administered at non-acupuncture (placebo) points;
• Non-invasive auricular 'seeds' administered at nonacupuncture (placebo) points.
Mean pain intensity on visual analogue scale (VAS) was similar in each group at baseline (57 to 58 mm). Each group received two courses of treatment with needles or seeds left in situ and were asked not to modify their analgesic medication during the course of the study.The duration of each course was determined by the time it took the needles to fall out or for the ear seeds to become unstuck and fall off. Pain scores were recorded at 1 month (termed D30 in the report) and 2 months (termed D60 in the report). Measures of electrodermal response at points on the ear were also taken at the same intervals. No adverse events were reported by either participants or their doctors. The main outcome measure was pain at 2 months, with secondary outcomes being pain at 1 month and electrodermal response at 1 and 2 months. The reported results showed a significant decrease in pain intensity of 36% (58 mm to 37 mm on VAS) from baseline at 2 months in the acupuncture group with an insignificant change in the group having acupuncture at placebo points (58 mm to 55 mm on VAS). The differences between the acupuncture and placebo acupuncture groups was statistically significant (P < 0.0001). Pain scores at 1 month were also lower in the true acupuncture group than either of the other two groups. Chen 2008 conducted a parallel group study comparing acupuncture to analgesic medication. This paper was written in Chinese and was translated by colleagues within our University Department to obtain a description of the methodology and results. Sixty six adult participants (age range of 41 to 70 years) with pain associated with "late" but unspecified cancer were categorised into groups according to pain severity -"mild", "moderate" and "severe". Participants received either acupuncture applied at 3 to 5 'tender' acupuncture points, or analgesic medication based on the World Health Organisation (WHO) 3-step principle and included aspirin for mild pain, codeine for moderate pain and morphine for severe pain. No placebo control group was included. Pain intensity was measured by change in visual analogue score. Participants were categorised into groups according to the change in pain intensity relative to baseline as follows:
• Complete Relief = visual analogue score (VAS) changes of 91 to 100% reduction in pain intensity from baseline.
• Average relief = VAS changes of 61 to 90% reduction in pain intensity from baseline.
• Partial relief = VAS changes of 31 to 60% reduction in pain intensity from baseline.
• No relief = VAS changes of less than 31% reduction in pain intensity from baseline.
The percentage of participants in each category falling into each of the above category was calculated and recorded and a cut-off point of pain relief of 31% or more set as criteria for "general effectiveness". It was concluded that the analgesic effect of acupuncture was significantly more effective than medication with the total effectiveness of acupuncture reported as 94% in the acupuncture group and 87.5% in the medication group (P < 0.05). It was not possible to extract data because no raw data or standard deviations were reported. Dang 1998 randomly allocated 48 participants with pain from stomach carcinoma to receive one of three treatments:
• Acupuncture (filiform needle) n = 16;
• Acupuncture point injection with human transfer factor n = 16;
• Western medicine (analgesic medication based on the WHO analgesic ladder) n = 16.
In addition a group of 16 healthy normal participants were as used as a control. This group did not receive any treatment and it was assumed that the control group was included for comparison of biochemical data over the course of the study (e.g. leukocyte count). Acupuncture was administered at 4 to 5 'main points' and 2 to 4 'auxiliary points' according to traditional acupuncture points and based on the patient's signs and symptoms. Needles remained in situ for 20 minutes. Treatment was given continuously for 2 weeks followed by a gap of 2 to 3 days before continuing. The total treatment period was 2 months. Each acupuncture treatment course consisted of one treatment per day for grade I pain and 2 to 3 sessions per day for grade II or III pain (according to the WHO criteria). For the point injection group an injection of 0.5 ml of freeze-dried human transfer factor aqueous solution was administered into four acupuncture points selected in a similar manner to the acupuncture group. This was done twice per week. Participants in the Western medicine group received analgesics including aspirin, indomethacin, AP-237, codeine, dihydrocodeine and dolantin, based on the WHO 3-step ladder. Transient effects (30 minutes after treatment) and long-term effects (12 hours posttreatment) were calculated for the first 10 days of treatment and the final 10 days of treatment over a 2 month period. At each stage of the study participants were categorised into groups according to the effectiveness of treatment: 'Markedly Effective', 'Improved' and 'Ineffective'. The percentage of participants in the 'Markedly Effective' and 'Improved' categories groups were used as a measure of effectiveness. No explanation was given as to how pain was measured and how participants were categorised into these groups even after referring to the earlier paper, Dang 1997, for further details. The results indicated that medication provided more effective analgesia during the first 10 days of treatment when considering both transient and long-term effects. During the final 10 days of treatment the transient effects of the acupuncture and point injection group were similar to the medication group and the longterm effects were equal (P > 0.05). However, taking only the longterm 'markedly effective' scores for the acupuncture (48.8%) and point injection (51.9%) groups during the final 10 days of treatment, these were significantly higher than in the medication group (33.8%) (both P < 0.05). A summary of the three included studies can be found in Table 2 .
Excluded studies
Most of the papers identified through our searches as being on acupuncture for cancer pain did not contain clinical data. After the initial screening by title and abstract, 17 studies remained and 13 of these were subsequently excluded. Two studies were excluded because they were not randomised (Aung 1994; Guo 1995). Two of the three studies that were not written in English were initially included (Meng 2002; Nguyen 2005) because a translation was not available at the initial screening. Translated abstracts were obtained at a later date which enabled us to exclude these studies as neither were clinical trials. Xia 1986 was excluded after discussion because pain was not a primary outcome measure and some of the participants were suffering from post-operative pain which excluded the study from the review. Poulain 1985 was also a study of postoperative pain and was excluded on this basis. The studies by Carr 2002 and Goudas 2001 were narrative reviews of the evidence and Yu 1992 was a discussion paper. Minton 2007 was a letter, although this wasn't clear in the initial screening by title and abstract. The study by Zhang 2006 fitted many of the inclusion criteria but was a study of herbal medicine for cancer pain with no acupuncture. A search conducted just prior to publication identified two further studies that were potentially eligible (Akhileswaran 2010; Sima 2009). Both of these studies were only available as conference abstracts with no traceable published papers and therefore did not meet our inclusion criteria. Contact details for the authors were not provided in either of the abstracts. Nevertheless, the work conducted by Sima 2009 is worthy of mention because it provides some clinical data from an RCT investigating the effects of electroacupuncture on neuropathic pain and other measures in patients with metastatic breast and lung cancer. The study found that acupuncture alleviated neuropathic bone pain and decreased consumption of analgesics as compared with a control group receiving acupuncture on non-acupuncture points. However, insufficient information was available within the abstract on the control group intervention.
Risk of bias in included studies
A modified version of the five-point Oxford Quality Scale (Jadad 1996; White 1999) was used to assess methodological quality (Table 1) . One study scored four out of five points and met the criteria for a high quality study (Alimi 2003) . This study lost one point for subject blinding because although the acupuncture and placebo acupuncture groups were blinded, participants receiving ear seeds were not blinded as the seeds had to be fixed with adhesive tape. The two remaining studies (Chen 2008; Dang 1998) both received two points out of five. They both lost one point for not reporting participant blinding, one point for not reporting assessor/evaluator blinding and one point for not reporting participant withdrawals/dropouts.These studies were therefore deemed to be of low methodological quality. Risk of bias was also assessed and this information is summarised in the Risk of bias in included studies and Figure 2 . It is clear from this information that although Alimi 2003 received the highest score for methodological quality according to the five-point scale, additional risk of bias' was introduced by the wide variation in the number of days the needles or ear seeds remained affixed to the ear and also in the fact that some of the participants changed their analgesic medication, which was contrary to the study protocol. 
Effects of interventions
Alimi 2003, found a significant decrease in pain intensity recorded on VAS at 1 month and 2 months. Participants in the true acupuncture group had significantly lower pain scores at 2 months than either the placebo acupuncture or ear seeds group (P < 0.001) with an overall 36% decrease in pain intensity as measured on a VAS. There was little change in pain intensity recorded for the placebo acupuncture group (2%). Chen 2008, reported that acupuncture was more effective (94.1%) as compared with medication (87.5%) (P < 0.05). The percentage of participants showing an improvement in VAS scores of 31% or more was used as a measure of 'general effectiveness' and the difference was tested again using chi squared. These results should be treated with caution as the description and reporting of the study is unclear and the method of analysis debatable. Dang 1998 reported that the western medication group experienced more effective immediate analgesia during the first 10 days than the filiform needle or point injection groups, but by the final 10 days the effects were similar. There were no significant differences between the groups in either transient or long-term effects. The use of ordinal categories for pain relief without specifying parameters make additional comparisons of trial data meaningless. Also, the pain outcomes in this study were linked to improving sleep and other quality of life criteria which presents a confusing picture.
D I S C U S S I O N Summary of main results
This review illustrates how few studies of acupuncture for cancer pain exist. We found no additional high-quality evidence since the last systematic review of acupuncture for cancer pain by Lee 2005. There remains only one high-quality study (Alimi 2003) which shows positive results for auricular (ear) acupuncture over placebo. A low-quality study on participants with stomach carcinoma (Dang 1998) failed to show a significant difference between conventional analgesia and acupuncture within the first 10 days of treatment, but indicated an increased long-term analgesic effect over western medicine during the final 10 days. Inadequacy of outcome measures, absence of reliable statistical methodology and failure to report blinding undermines this evidence. A low quality study reported significant benefits of acupuncture over conventional medication (Chen 2008) although the method of analysis was poor and raw data was not available. The study was poorly reported with no mention of blinding. The heterogeneity of methodologies, cancer populations and techniques used in the included studies precluded pooling of data and therefore metaanalysis was not carried out. A subgroup analysis on acupuncture for CIBP was not conducted because none of the studies made any reference to bone pain. When adequacy of acupuncture dose was examined the high-quality auricular study (Alimi 2003) reported the use of an average of six auricular points and an average treatment duration was 44 minutes. This partially meets the criteria for adequacy as suggested by White 2007, but it was unclear how many treatments were carried out and needle sensation was not reported. One low quality study used less than six needles and did not report the frequency of treatment sessions (Chen 2008). The other low quality study reported adequate duration, frequency and points used but the frequency of treatment varied depending on the level of pain reported (Dang 1998). Reference was made to achieving 'de qi' (needle sensation) in just one of the studies (Dang 1998) which mentioned the need to concentrate the mind on the diseased site to promote needle sensation.
A U T H O R S ' C O N C L U S I O N S Implications for practice
The evidence from one high-quality RCT is insufficient to provide a judgement on whether acupuncture is effective in treating cancerrelated pain in adults, although acupuncture is used quite widely for this purpose and for other cancer-related conditions. As peerreviewed guidelines exist for the use of acupuncture in cancer patients (Filshie 2006) it is suggested that practitioners follow these guidelines and that patients are made aware of the potential limitations of this type of intervention.
Implications for research
Acupuncture is widely used to treat cancer-related pain, but the available evidence is inconclusive or of low quality. Therefore a judgement on whether acupuncture is effective cannot be made and more large RCTs are required with particular attention given to:
• power calculations to ensure adequate sample sizes;
• homogeneity of cancer pain conditions under study;
• use of optimal dose of acupuncture;
• assessor blinding;
• use of valid and reliable pain outcome measures;
• the nature of the control used. As no studies investigating acupuncture for CIBP were identified, this is an area which should be specifically targeted for further research.
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